Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
Background: Metastatic castration-resistant prostate cancer (CRPC) is the leading cause of death among prostate cancer patients. Here, our aim was to ascertain the immune regulatory mechanisms involved in CRPC development and identify potential immunotherapies against CRPC. Methods: A CRPC model was...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/fd436a2d1e8b4d2a9fc27ac955ff189d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|